3. Highlights in the Period
• Consolidated gross revenues amounted to R$ 1.0 billion, up 10.6% year-over-year and EBITDA rose by 6.3% to R$ 33.1
million in the same period;
• The Pharmaceutical Distribution division grew sharply by 10.3% year-over-year;
• The Hospital & Specialties division expanded by 12.2% year-over-year and by 17.3% quarter-over-quarter;
• After approval by the regulatory bodies (CADE), Profarma posts the results for the month of June of its retail operation
Tamoio. In this period, it grew by 10.8% year-over-year, with a 4.4% EBITDA margin;
• SAP was introduced as an Integrated System in the Tamoio chain’s financial and accounting divisions in June 2013,
whereas at Arpmed, the development of the SAP System was initiated in April and came to completion in August;
• The consolidated cash cycle was decreased by 2.8 days to 56.3 days. This decrease resulted in a fall of about R$ 24.8
million in working capital.
5. Gross Profit Revenues from Services to Suppliers Gross Profit Margin (%)
(R$ million and % Net Revenues)
Gross Profit and Revenues from Services to Suppliers
2Q12
42.0
52.8
1Q13
37.3
58.5
2Q13
31.3
82.5
12.9%
12.4%
11.2%
11. * Average
(1) Average of Gross Revenues in the Quarter
(2) Average of COGS in the Quarter
(3) Average of COGS in the Quarter
Cash Cycle - Days *
Accounts Receivable (1)
Inventories (2)
Accounts Payable (3)
55.1
49.1
47.9
2Q13
56.3
59.5
47.4
55.8
1Q13
51.1
47.4
48.9
37.1
2Q12
59.1
14. Nível de Serviço
(Unidades atendidas / Unidades pedidas)
Logistics E.P.M.
(Errors per Million)
2Q12
87.9%
2Q13
88.9%
1Q13
87.4%
2Q12
107.0
118.0
2Q131Q13
115.0
15. Gross Revenues
R$ million
28.7
Op. Exp.
Total
Gross
Margin
Ebitda
Margin
Net
Margin
24.0%
28.6%
Financial DataTamoio – jun/13
(R$ million e % Gross Revenues)
57
7
8.7%
25.35
503.1
21.2
# of stores
Store Openings
1
SSS Mature Stores (more than 36 months)
Average Ticket (in reais)
Average Store's Sales
Revenues per Employee
1- Same Store Sales
8.1%1SSS
Operational Data Tamoio – jun/13
(R$ thousands)
4.4% 3.7%
16. Turnover - PFRM3 PFRM3 IBOV Index IGCX Index
Stock Performance
100
8.3
-8.7
-22.1
100
17. Analyst Coverage
Company Analyst Phone number Email address
Credit Suisse Marcel Moraes (55 11) 3841-6302 marcel.moraes@credit-suisse.com
BTG Pactual João Carlos dos Santos (55 11) 3383-2384 joaocarlos.santos@btgpactual.com
Juliana Rozenbaum (55 11) 3073-3040 juliana.rozenbaum@itausecurities.comItaú BBA
Javier Martinez de Olcoz (55 11) 3048-6088 javier.martinez.olcoz@morganstanley.comMorgan Stanley
Andre Parize (55 11) 5171-5870 andre.parize@votorantimcorretora.com.brVotorantim
Merrill Lynch Mauricio Fernandes (55 11) 2188-4236 mauricio.fernandes@baml.com
Banco Fator Pedro Ivo Barreto Zabeu (55 11) 3049-9478 pzabeu@bancofator.com.br
Guilherme Assis (55 11) 3206-8285 guilherme.assis@brasilplural.com.brBrasil Plural
18. Contatos RI
Max Fischer | Diretor Financeiro e de RI
Beatriz Diez | Gerente de RI
Telefone.: 55 (21) 4009-0276 | E-mail: ri@profarma.com.br | www.profarma.com.br/ri
IR contacts
Max Fischer | Chief Financial and IR Officer
Beatriz Diez | IR Manager
Phone number: 55 (21) 4009-0276 | E-mail: ri@profarma.com.br | www.profarma.com.br/ir